EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Marein ameliorates the progression of osteoarthritis: An in vitro and in vivo studies

Li Yin, Zeju He, Yong Fan, Zexuan Niu, Longtao Yao, Sheyuan Ding, Jihang Chen, Qiong Zhang, Yu Tong, Qing Bi, Li Cao

International Immunopharmacology · 2025-01 · 144 · 113695

DOI: 10.1016/j.intimp.2024.113695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-01. Verfasst von Li Yin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sports Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Osteoarthritis, NF-E2-Related Factor 2, Nitric Oxide Synthase Type II. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Administration Bureau of Traditional Chinese Medicine, Zhejiang Province Public Welfare Technology Application Research Project, Medical Science and Technology Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a prevalent, degenerative joint disease that requires effective treatments to prevent its progression. Therefore, the development of novel therapeutic strategies to address this unmet clinical challenge is paramount. Marein (MA), the principal active compound of Coreopsis tinctoria Nutt, exhibits anti-inflammatory and anti-oxidant properties in various diseases, indicating its potential as a therapeutic agent for OA. In this study, we assessed the ability of marein to mitigate the inflammatory response in OA and reverse cartilage degradation. The results demonstrated that MA exerted a concentration -dependent effect (10, 25, 50 μM), facilitating the nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2), reversing the suppression of nuclear factor kappa B (NF-κB) activation, and mitigating the inflammatory response, ultimately alleviating joint cartilage damage. In cellular assays, MA (10, 25, 50 μM) markedly decreased the expression of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), matrix metalloproteinase-13 (MMP-13) and a metalloproteinase with thrombospondin motifs 5 (ADAMTS-5), simultaneously decreasing reactive oxygen species production by enhancing Nrf2 nuclear translocation. Furthermore, in animal models, MA (50 μM) significantly improved knee joint cartilage damage and effectively reduced OA progression. Further studies are needed to determine the long-term safety and therapeutic potential of MA and to expand its application scope. Moreover, preclinical studies are required to evaluate the efficacy of MA in humans. Overall, MA is a promising therapeutic candidate and may be an effective treatment for patients with OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory AgentsOsteoarthritisNF-E2-Related Factor 2Nitric Oxide Synthase Type IIChondrocytesCyclooxygenase 2Disease ProgressionAnimalsHumansMaleCartilage, ArticularNF-kappa BMatrix Metalloproteinase 13ADAMTS5 ProteinRatsMiceRats, Sprague-DawleyDisease Models, AnimalReactive Oxygen Species

Stichwörter der Autor:innen

Anti-inflammatoryIL-1βMareinNrf2/HO-1/NF-κBOsteoarthritisROS

Substanzen

Anti-Inflammatory AgentsNF-E2-Related Factor 2Nitric Oxide Synthase Type IICyclooxygenase 2NF-kappa BMatrix Metalloproteinase 13ADAMTS5 ProteinReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Sports Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310000, China; Postgraduate Training Base Alliance of Wenzhou Medical Uni…
  • Department of Sports Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310000, China; Center for Rehabilitation Medicine, Department of Orthoped…
  • Department of Nursing, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang 310000, China.

Förderung

  • Zhejiang Administration Bureau of Traditional Chinese Medicine
  • Zhejiang Province Public Welfare Technology Application Research Project
  • Medical Science and Technology Project of Zhejiang Province

Zitieren

APA

Yin, L., He, Z., Fan, Y., Niu, Z., Yao, L., Ding, S., Chen, J., Zhang, Q., Tong, Y., Bi, Q., & Cao, L. (2025). Marein ameliorates the progression of osteoarthritis: An in vitro and in vivo studies. International Immunopharmacology, 144, 113695. https://doi.org/10.1016/j.intimp.2024.113695

Vancouver

Yin L, He Z, Fan Y, Niu Z, Yao L, Ding S, et al. Marein ameliorates the progression of osteoarthritis: An in vitro and in vivo studies. International Immunopharmacology. 2025;144:113695. doi:10.1016/j.intimp.2024.113695

BibTeX
@article{Yin2025,
  author = {Yin, Li and He, Zeju and Fan, Yong and Niu, Zexuan and Yao, Longtao and Ding, Sheyuan and Chen, Jihang and Zhang, Qiong and Tong, Yu and Bi, Qing and Cao, Li},
  title = {Marein ameliorates the progression of osteoarthritis: An in vitro and in vivo studies},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {144},
  pages = {113695},
  doi = {10.1016/j.intimp.2024.113695}
}
Kostenlos starten →